(Q39845365)

English

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

0 references

0 references

Frédéric Clement

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Patricia Bourguignon

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Isabel Leroux-Roels

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Marguerite Koutsoukos

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sophia Steyaert

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Michel Janssens

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Kristen Cohen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Pierre Vandepapelière

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Louise Pedneault

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Lisa McNally

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Gerald Voss

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Geert Leroux-Roels

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

0 references

publication date

20 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

7016-7024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Scientific and policy challenges to development of an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

HIV vaccine design and the neutralizing antibody problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

CD8 lethargy in the absence of CD4 help.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Virus-specific cellular immune correlates of survival in vaccinated monkeys after simian immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Vaccine adjuvants revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

HIV vaccines: new frontiers in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Follicular helper T cells as cognate regulators of B cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Lymphocyte Subsets in Normal Human Lymphoid Tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Mechanism of antigen-driven selection in germinal centres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Signals that influence T follicular helper cell differentiation and function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

HIV preferentially infects HIV-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Progress in defining CD4 helper cell responses in chronic viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Loss of HIV-1-specific T-cell responses associated with very rapid HIV-1 disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

HIV T cell vaccines, the importance of clades

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

An HIV vaccine--evolving concepts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Antibody-based HIV-1 vaccines: recent developments and future directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Estimated Global Distribution and Regional Spread of HIV-1 Genetic Subtypes in the Year 2000

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

based on heuristic

inferred from DOI database lookup

1 Statistical analysis of radioligand assay data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.035

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.08.035

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

release_ie4vbrqpenhd3lhanpybwctcxq

1 reference

https://api.fatcat.wiki/v0/release/ie4vbrqpenhd3lhanpybwctcxq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728522%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39845365&oldid=2091399108"